Amgen's Lourie Zak joins PBS Biotech as CFO
This article was originally published in Scrip
PBS Biotech, a supplier of innovative single-use bioreactors for the biotechnology market, has appointed Lourie Zak chief financial officer. For the past eight years, Ms Zak has served at Amgen in roles of increasing responsibility, most recently as executive director of finance for the company's global commercial operations at its California-based headquarters.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.